Lion Point Capital, LP - Q2 2020 holdings

$412 Million is the total value of Lion Point Capital, LP's 24 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 28.0% .

 Value Shares↓ Weighting
CSIQ  CANADIAN SOLAR INC$82,573,000
+21.1%
4,285,0660.0%20.03%
+11.3%
DRRX SellDURECT CORP$43,136,000
+42.8%
18,593,303
-4.6%
10.46%
+31.2%
ACHC  ACADIA HEALTHCARE COMPANY IN$39,148,000
+36.9%
1,558,4720.0%9.49%
+25.8%
MRNS BuyMARINUS PHARMACEUTICALS INC$27,618,000
+113.4%
10,873,340
+70.6%
6.70%
+96.1%
LBTYA BuyLIBERTY GLOBAL PLC$27,325,000
+74.2%
1,250,000
+31.6%
6.63%
+60.1%
PRSP  PERSPECTA INC$20,907,000
+27.4%
900,0000.0%5.07%
+17.1%
SWIR  SIERRA WIRELESS INC$19,256,000
+58.1%
2,144,3960.0%4.67%
+45.3%
AA  ALCOA CORP$19,089,000
+82.5%
1,698,3820.0%4.63%
+67.7%
PDCE  PDC ENERGY INC$18,238,000
+100.3%
1,466,0790.0%4.42%
+84.1%
TGTX NewTG THERAPEUTICS INC$17,489,000897,799
+100.0%
4.24%
ARNC NewARCONIC CORPORATION$16,280,0001,168,749
+100.0%
3.95%
BATL  BATTALION OIL CORP$13,584,000
+103.2%
1,429,9760.0%3.29%
+86.7%
KNSA  KINIKSA PHARMACEUTICALS LTD$12,631,000
+64.6%
495,7480.0%3.06%
+51.3%
XOP SellSPDR SER TRput$12,393,000
+19.1%
237,500
-24.9%
3.01%
+9.5%
LSCC SellLATTICE SEMICONDUCTOR CORP$11,872,000
-65.5%
418,188
-78.4%
2.88%
-68.3%
LUMO  LUMOS PHARMA INC$6,714,000
+94.0%
407,1920.0%1.63%
+78.3%
SCOR  COMSCORE INC$5,958,000
+9.9%
1,922,2410.0%1.44%
+1.0%
OUT  OUTFRONT MEDIA INC$4,251,000
+5.1%
300,0000.0%1.03%
-3.4%
LOGC  LOGICBIO THERAPEUTICS INC$4,230,000
+71.3%
500,0000.0%1.03%
+57.4%
EXTR  EXTREME NETWORKS INC$3,523,000
+40.5%
811,8350.0%0.85%
+29.0%
AGLE NewAEGLEA BIOTHERAPEUTICS INC$2,775,000300,000
+100.0%
0.67%
OPESU  OPES ACQUISITION CORPunit 03/07/2023$1,939,000
+142.7%
83,4380.0%0.47%
+122.7%
OVV  OVINTIV INC$860,000
+253.9%
90,1080.0%0.21%
+226.6%
LBTYK  LIBERTY GLOBAL PLC$537,000
+37.0%
25,0000.0%0.13%
+26.2%
XEC ExitCIMAREX ENERGY CO$0-35,162
-100.0%
-0.16%
CPE ExitCALLON PETE CO DEL$0-8,202,705
-100.0%
-1.19%
L100PS ExitARCONIC INC$0-675,000
-100.0%
-2.86%
IWM ExitISHARES TRput$0-705,000
-100.0%
-21.30%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CANADIAN SOLAR INC21Q2 202125.6%
ALCOA CORP21Q1 20228.0%
ISHARES TR19Q3 202339.2%
COMSCORE INC19Q4 20225.8%
HALCON RES CORP15Q3 20233.3%
KINIKSA PHARMACEUTICALS LTD15Q3 20233.1%
LUMOS PHARMA INC15Q3 20232.8%
DURECT CORP14Q3 202210.5%
ARCONIC INC14Q1 20204.4%
MARINUS PHARMACEUTICALS INC13Q3 202311.6%

View Lion Point Capital, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Lion Point Capital, LP Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SIERRA WIRELESS INCJune 07, 20221,810,6714.7%
BATTALION OIL CORPFebruary 14, 2022352,8512.2%
DURECT CORPFebruary 14, 202215,486,0046.8%
LUMOS PHARMA, INC.February 12, 2021407,1924.9%
BurgerFi International, Inc.January 11, 20212,745,93815.7%
Canadian Solar Inc.November 27, 20202,453,7244.1%
NEWLINK GENETICS CORPFebruary 14, 20203,114,7338.3%
CARRIZO OIL & GAS INCOctober 29, 20194,584,4005.0%
LATTICE SEMICONDUCTOR CORPJuly 22, 20196,467,0354.9%
Cimarex Resolute LLCMarch 05, 2019? ?

View Lion Point Capital, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14
13F-HR2022-11-14

View Lion Point Capital, LP's complete filings history.

Compare quarters

Export Lion Point Capital, LP's holdings